For citations:
Gusev D.A., Zhdanov K.V., Kozlov K.V., Vinogradova T.N., Kopot M.Yu., Sukachev V.S., Zhabrov S.S., Kizhlo S.N., Romanova S.Yu., Musatov V.B., Tyurenkova N.V., Vlasova Yu.A., Kolpashchikova E.Yu., Fedorov P.N., Minin P.V., Korneeva T.S. Real-world effectiveness and safety of pan-genotypic antiviral therapy for chronic HCV-infection: data from three clinical centers in St. Petersburg. Journal Infectology. 2022;14(5):60-68. (In Russ.) https://doi.org/10.22625/2072-6732-2022-14-5-60-68